A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016
Purpose To compare the epidemiology of epithelioid (ED), spindle cell (SC), and mixed epithelioid‐spindle cell (MES) tumor subtypes of uveal melanoma (UM). Methods Data were extracted from the Surveillance, Epidemiology, and End Results U.S. cancer database from 1975 to 2016. Incidence (IR) was esti...
Gespeichert in:
Veröffentlicht in: | Acta ophthalmologica (Oxford, England) England), 2021-01, Vol.99 (S265), p.n/a |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | S265 |
container_start_page | |
container_title | Acta ophthalmologica (Oxford, England) |
container_volume | 99 |
creator | Tadrosse, Abanoob Mikhael, Sandra Tadrosse, Marina Mikhael, Mina Eloy, Jean A. |
description | Purpose
To compare the epidemiology of epithelioid (ED), spindle cell (SC), and mixed epithelioid‐spindle cell (MES) tumor subtypes of uveal melanoma (UM).
Methods
Data were extracted from the Surveillance, Epidemiology, and End Results U.S. cancer database from 1975 to 2016. Incidence (IR) was estimated in number of cases/million/year. Incidence (IR) trends across the study's timeframe were assessed by measuring the annual percent change (APC). Disease‐specific survival (DSS) was calculated using the Kaplan‐Meier method. Cox regression analyses were conducted to evaluate hazard ratios (HR).
Results
Two thousand nine hundred thirty‐eight cases were identified: MES‐UM (38%), SC‐UM (49%), ED‐UM (13%). Diagnostic age in years was significantly different (MES‐UM, 63; SC‐UM, 58; ED‐UM, 63; p |
doi_str_mv | 10.1111/j.1755-3768.20200203 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2478357347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2478357347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1693-effdc4142a752a5abd22992c6452e3855e21922b0d5ea50ce0bd85e2a2bc01d03</originalsourceid><addsrcrecordid>eNqNkUtOwzAQhiMEEqVwAxaW2DbFduI8llXFS6rUBSCxsxx7Ao6cOsQJ0F2PgMSC-_UkJC1UXTKyNKPx9_-WZzzvnOAx6eKyGJOYMT-Io2RMMcXdCQ68wa55uKvZ07F34lyBcUSiKBx43xMkbVmJWjT6DRBUWkGprbHPWgqDxEKYpdMO2by_a17AaKvVCLlKL5QBJMGYUYcpVOoPUPvQevW5T6GmLW2NXJs1ywo2ju0bdG-UYMTClmKESBoH69UXxSQ69Y5yYRyc_eah93h99TC99Wfzm7vpZOZLEqWBD3muZEhCKmJGBROZojRNqYxCRiFIGANKUkozrBgIhiXgTCVdU9BMYqJwMPQutr5VbV9bcA0vbFt3v3achnESsDgI444Kt5SsrXM15LyqdSnqJSeY9yvgBe8nzPtp878VdLJ0K3vXBpb_0vDJ_H6j_QGvco3E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478357347</pqid></control><display><type>article</type><title>A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016</title><source>Wiley Free Content</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tadrosse, Abanoob ; Mikhael, Sandra ; Tadrosse, Marina ; Mikhael, Mina ; Eloy, Jean A.</creator><creatorcontrib>Tadrosse, Abanoob ; Mikhael, Sandra ; Tadrosse, Marina ; Mikhael, Mina ; Eloy, Jean A.</creatorcontrib><description><![CDATA[Purpose
To compare the epidemiology of epithelioid (ED), spindle cell (SC), and mixed epithelioid‐spindle cell (MES) tumor subtypes of uveal melanoma (UM).
Methods
Data were extracted from the Surveillance, Epidemiology, and End Results U.S. cancer database from 1975 to 2016. Incidence (IR) was estimated in number of cases/million/year. Incidence (IR) trends across the study's timeframe were assessed by measuring the annual percent change (APC). Disease‐specific survival (DSS) was calculated using the Kaplan‐Meier method. Cox regression analyses were conducted to evaluate hazard ratios (HR).
Results
Two thousand nine hundred thirty‐eight cases were identified: MES‐UM (38%), SC‐UM (49%), ED‐UM (13%). Diagnostic age in years was significantly different (MES‐UM, 63; SC‐UM, 58; ED‐UM, 63; p < 0.01). Incidence (IR) also differed: MES‐UM, 0.8; SC‐UM, 0.7; ED‐UM, 0.2 (p < 0.01). Incidence (IR) declined over the study's time period with APC values of −4.5 (p < 0.01; MES‐UM), −2.8 (p < 0.01; SC‐UM), and −2.7 (p = 0.04; ED‐UM). Five‐year DSS for patients diagnosed during 1995–2000 were 74.6% (MES‐UM), 86.4% (SC‐UM), and 56.2% (ED‐UM). In comparison, Five‐year DSS during 2006–2011 was similar for SC‐UM (91.8%; p = 0.07) and ED‐UM (58.4%; p = 0.35), but significantly declined for MES‐UM (57.6%; p < 0.01). MES‐UM patients aged 30‐50 years old exhibited favorable prognosis compared to older or younger ones (HR: 0.53; p = 0.023). Asian and black races portended poor prognoses for ED‐UM (HR: 2.7; p = 0.04) and SC‐UM (HR: 2.9; p = 0.03), respectively. Advanced stage at diagnosis was not a survival predictor in MES‐UM patients, but it predicted poor prognosis in ED‐UM (HR: 4.8; p < 0.01) and SC‐UM (HR: 5.7; p < 0.001).
Conclusions
Diagnostic age is youngest for SC‐UM. Incidence (IR) for all subtypes has declined. Disease‐specific survival (DSS) was stable over the study’s timeframe for SC‐UM and ED‐UM but substantially worsened for MES‐UM. Age impacts MES‐UM prognosis. Asian and black races are negative prognostic factors for ED‐UM and SC‐UM, respectively. Disease stage is a survival predictor only for ED‐UM and SC‐UM.]]></description><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/j.1755-3768.20200203</identifier><language>eng</language><publisher>Malden: Wiley Subscription Services, Inc</publisher><subject>Adenomatous polyposis coli ; Age ; Epidemiology ; Medical prognosis ; Melanoma ; Prognosis ; Races</subject><ispartof>Acta ophthalmologica (Oxford, England), 2021-01, Vol.99 (S265), p.n/a</ispartof><rights>2021 The Authors Acta Ophthalmologica © 2021 Acta Ophthalmologica Scandinavica Foundation</rights><rights>Copyright © 2021 Acta Ophthalmologica Scandinavica Foundation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1755-3768.20200203$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45551,46808</link.rule.ids></links><search><creatorcontrib>Tadrosse, Abanoob</creatorcontrib><creatorcontrib>Mikhael, Sandra</creatorcontrib><creatorcontrib>Tadrosse, Marina</creatorcontrib><creatorcontrib>Mikhael, Mina</creatorcontrib><creatorcontrib>Eloy, Jean A.</creatorcontrib><title>A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016</title><title>Acta ophthalmologica (Oxford, England)</title><description><![CDATA[Purpose
To compare the epidemiology of epithelioid (ED), spindle cell (SC), and mixed epithelioid‐spindle cell (MES) tumor subtypes of uveal melanoma (UM).
Methods
Data were extracted from the Surveillance, Epidemiology, and End Results U.S. cancer database from 1975 to 2016. Incidence (IR) was estimated in number of cases/million/year. Incidence (IR) trends across the study's timeframe were assessed by measuring the annual percent change (APC). Disease‐specific survival (DSS) was calculated using the Kaplan‐Meier method. Cox regression analyses were conducted to evaluate hazard ratios (HR).
Results
Two thousand nine hundred thirty‐eight cases were identified: MES‐UM (38%), SC‐UM (49%), ED‐UM (13%). Diagnostic age in years was significantly different (MES‐UM, 63; SC‐UM, 58; ED‐UM, 63; p < 0.01). Incidence (IR) also differed: MES‐UM, 0.8; SC‐UM, 0.7; ED‐UM, 0.2 (p < 0.01). Incidence (IR) declined over the study's time period with APC values of −4.5 (p < 0.01; MES‐UM), −2.8 (p < 0.01; SC‐UM), and −2.7 (p = 0.04; ED‐UM). Five‐year DSS for patients diagnosed during 1995–2000 were 74.6% (MES‐UM), 86.4% (SC‐UM), and 56.2% (ED‐UM). In comparison, Five‐year DSS during 2006–2011 was similar for SC‐UM (91.8%; p = 0.07) and ED‐UM (58.4%; p = 0.35), but significantly declined for MES‐UM (57.6%; p < 0.01). MES‐UM patients aged 30‐50 years old exhibited favorable prognosis compared to older or younger ones (HR: 0.53; p = 0.023). Asian and black races portended poor prognoses for ED‐UM (HR: 2.7; p = 0.04) and SC‐UM (HR: 2.9; p = 0.03), respectively. Advanced stage at diagnosis was not a survival predictor in MES‐UM patients, but it predicted poor prognosis in ED‐UM (HR: 4.8; p < 0.01) and SC‐UM (HR: 5.7; p < 0.001).
Conclusions
Diagnostic age is youngest for SC‐UM. Incidence (IR) for all subtypes has declined. Disease‐specific survival (DSS) was stable over the study’s timeframe for SC‐UM and ED‐UM but substantially worsened for MES‐UM. Age impacts MES‐UM prognosis. Asian and black races are negative prognostic factors for ED‐UM and SC‐UM, respectively. Disease stage is a survival predictor only for ED‐UM and SC‐UM.]]></description><subject>Adenomatous polyposis coli</subject><subject>Age</subject><subject>Epidemiology</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Prognosis</subject><subject>Races</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqNkUtOwzAQhiMEEqVwAxaW2DbFduI8llXFS6rUBSCxsxx7Ao6cOsQJ0F2PgMSC-_UkJC1UXTKyNKPx9_-WZzzvnOAx6eKyGJOYMT-Io2RMMcXdCQ68wa55uKvZ07F34lyBcUSiKBx43xMkbVmJWjT6DRBUWkGprbHPWgqDxEKYpdMO2by_a17AaKvVCLlKL5QBJMGYUYcpVOoPUPvQevW5T6GmLW2NXJs1ywo2ju0bdG-UYMTClmKESBoH69UXxSQ69Y5yYRyc_eah93h99TC99Wfzm7vpZOZLEqWBD3muZEhCKmJGBROZojRNqYxCRiFIGANKUkozrBgIhiXgTCVdU9BMYqJwMPQutr5VbV9bcA0vbFt3v3achnESsDgI444Kt5SsrXM15LyqdSnqJSeY9yvgBe8nzPtp878VdLJ0K3vXBpb_0vDJ_H6j_QGvco3E</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Tadrosse, Abanoob</creator><creator>Mikhael, Sandra</creator><creator>Tadrosse, Marina</creator><creator>Mikhael, Mina</creator><creator>Eloy, Jean A.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>202101</creationdate><title>A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016</title><author>Tadrosse, Abanoob ; Mikhael, Sandra ; Tadrosse, Marina ; Mikhael, Mina ; Eloy, Jean A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1693-effdc4142a752a5abd22992c6452e3855e21922b0d5ea50ce0bd85e2a2bc01d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenomatous polyposis coli</topic><topic>Age</topic><topic>Epidemiology</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Prognosis</topic><topic>Races</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tadrosse, Abanoob</creatorcontrib><creatorcontrib>Mikhael, Sandra</creatorcontrib><creatorcontrib>Tadrosse, Marina</creatorcontrib><creatorcontrib>Mikhael, Mina</creatorcontrib><creatorcontrib>Eloy, Jean A.</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tadrosse, Abanoob</au><au>Mikhael, Sandra</au><au>Tadrosse, Marina</au><au>Mikhael, Mina</au><au>Eloy, Jean A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><date>2021-01</date><risdate>2021</risdate><volume>99</volume><issue>S265</issue><epage>n/a</epage><issn>1755-375X</issn><eissn>1755-3768</eissn><abstract><![CDATA[Purpose
To compare the epidemiology of epithelioid (ED), spindle cell (SC), and mixed epithelioid‐spindle cell (MES) tumor subtypes of uveal melanoma (UM).
Methods
Data were extracted from the Surveillance, Epidemiology, and End Results U.S. cancer database from 1975 to 2016. Incidence (IR) was estimated in number of cases/million/year. Incidence (IR) trends across the study's timeframe were assessed by measuring the annual percent change (APC). Disease‐specific survival (DSS) was calculated using the Kaplan‐Meier method. Cox regression analyses were conducted to evaluate hazard ratios (HR).
Results
Two thousand nine hundred thirty‐eight cases were identified: MES‐UM (38%), SC‐UM (49%), ED‐UM (13%). Diagnostic age in years was significantly different (MES‐UM, 63; SC‐UM, 58; ED‐UM, 63; p < 0.01). Incidence (IR) also differed: MES‐UM, 0.8; SC‐UM, 0.7; ED‐UM, 0.2 (p < 0.01). Incidence (IR) declined over the study's time period with APC values of −4.5 (p < 0.01; MES‐UM), −2.8 (p < 0.01; SC‐UM), and −2.7 (p = 0.04; ED‐UM). Five‐year DSS for patients diagnosed during 1995–2000 were 74.6% (MES‐UM), 86.4% (SC‐UM), and 56.2% (ED‐UM). In comparison, Five‐year DSS during 2006–2011 was similar for SC‐UM (91.8%; p = 0.07) and ED‐UM (58.4%; p = 0.35), but significantly declined for MES‐UM (57.6%; p < 0.01). MES‐UM patients aged 30‐50 years old exhibited favorable prognosis compared to older or younger ones (HR: 0.53; p = 0.023). Asian and black races portended poor prognoses for ED‐UM (HR: 2.7; p = 0.04) and SC‐UM (HR: 2.9; p = 0.03), respectively. Advanced stage at diagnosis was not a survival predictor in MES‐UM patients, but it predicted poor prognosis in ED‐UM (HR: 4.8; p < 0.01) and SC‐UM (HR: 5.7; p < 0.001).
Conclusions
Diagnostic age is youngest for SC‐UM. Incidence (IR) for all subtypes has declined. Disease‐specific survival (DSS) was stable over the study’s timeframe for SC‐UM and ED‐UM but substantially worsened for MES‐UM. Age impacts MES‐UM prognosis. Asian and black races are negative prognostic factors for ED‐UM and SC‐UM, respectively. Disease stage is a survival predictor only for ED‐UM and SC‐UM.]]></abstract><cop>Malden</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1111/j.1755-3768.20200203</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1755-375X |
ispartof | Acta ophthalmologica (Oxford, England), 2021-01, Vol.99 (S265), p.n/a |
issn | 1755-375X 1755-3768 |
language | eng |
recordid | cdi_proquest_journals_2478357347 |
source | Wiley Free Content; Wiley Online Library Journals Frontfile Complete |
subjects | Adenomatous polyposis coli Age Epidemiology Medical prognosis Melanoma Prognosis Races |
title | A comparative epidemiological analysis of epithelioid, spindle cell, and mixed epithelioid‐spindle cell tumor subtypes of uveal melanoma, 1973–2016 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparative%20epidemiological%20analysis%20of%20epithelioid,%20spindle%20cell,%20and%20mixed%20epithelioid%E2%80%90spindle%20cell%20tumor%20subtypes%20of%20uveal%20melanoma,%201973%E2%80%932016&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=Tadrosse,%20Abanoob&rft.date=2021-01&rft.volume=99&rft.issue=S265&rft.epage=n/a&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/j.1755-3768.20200203&rft_dat=%3Cproquest_cross%3E2478357347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478357347&rft_id=info:pmid/&rfr_iscdi=true |